TrialPath
← Back to searchRecruiting

Achieving Routine Intervention and Screening for Emotional Health

NCT06887049 · University of Chicago
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
ARISE: Achieving Routine Intervention and Screening for Emotional Health: Randomized Controlled Trial
About this study
Diabetes mellitus (DM) affects 30 million people in the U.S.1 The prevalence of diabetes is higher among Hispanics (12.5%) and African Americans (11.7%) compared to non-Hispanic whites (7.5%). Managing type 2 DM (T2DM) can be complex and burdensome; patients must modify their diet and exercise habits, take medications, check their blood sugars, visits their healthcare providers regularly, and navigate work and family life. Financial insecurity and social risks (e.g., transportation access) also disproportionately affect persons of color in the U.S. and in turn impede patients' ability to adhere to diabetes self-care recommendations. Diabetes distress (DD) is the stress, fear, and guilt in having to manage diabetes and is distinct from depression and anxiety. A meta-analysis of 58 international studies noted one in five adults with diabetes had elevated DD.6 DD has well documented associations with poor medication adherence, dietary and exercise behaviors, quality of life, and glycosylated hemoglobin (A1C). African-Americans and Hispanics have higher levels of DD compared to non-Hispanic whites. The American Diabetes Association published guidelines promoting screening for and addressing DD as a critical part of clinical care. Multiple studies have tested standardized screening instruments for DD and intervention studies have demonstrated reductions in DD. However, only 24% of adults with diabetes report their health care team asked them how diabetes affected their lives and far fewer currently receive structured DD screening and follow-up. Efforts to systematically identify and address DD could be an important strategy to improve diabetes outcomes and address diabetes disparities. Community health centers (CHCs) can be important partners in this effort. CHCs provide primary care for 2.5 million adults with diabetes, of whom 30% have A1C \>9% and 57% are racial ethnic minorities. No studies have systematically implemented DD screening and treatment interventions into a real-world primary care setting or used a guideline based approach. To fill this gap, we developed the ARISE (Achieving Routine Intervention and Screening for Emotional health) intervention. ARISE is a primary care training and implementation program for clinicians and allied health professionals to support screening for and address DD in T2DM. ARISE utilizes a standardized process for screening adult patients with T2DM for DD using validated instruments, provides training and support for CHC staff applying evidence-based strategies on how to address DD in the encounter, and an algorithm for action steps and referrals based on individualized sources of DD (e.g. hypoglycemia, access based on social needs). This pragmatic study will compare ARISE to enhanced usual care (didactic lecture for clinical staff on emotional health of persons with diabetes) using a type I hybrid effectiveness-implementation design via a cluster randomized controlled trial. This study provides the opportunity to optimize T2DM care for populations with health disparities concordant with evidence-based guidelines to aid in the attainment of optimal glycemic control.
Eligibility criteria
Inclusion Criteria: * Patient at a participating clinic * Type 2 diabetes * Adult (18 years or older) * A1C \> 8% Exclusion Criteria: * Pregnant
Study design
Enrollment target: 1250 participants
Allocation: randomized
Masking: none
Age groups: adult, older_adult
Timeline
Starts: 2026-03-03
Estimated completion: 2028-09
Last updated: 2026-03-06
Interventions
Behavioral: ARISE Learning Community Diabetes Distress Screening and InterventionBehavioral: ARISE Enhanced Care brief training
Primary outcomes
  • Rate of A1C across time (12 months)
Sponsor
University of Chicago · other
With: University of California, San Francisco, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Midwest Clinicians' Network
Contacts & investigators
ContactAbby Sr. Research Project Manager, MSW · contact · abigail.durgan@bsd.uchicago.edu · 773-834-5646
InvestigatorArshiya Baig, MD, MPH · principal_investigator, University of Chicago
InvestigatorDanielle Hessler Jones, PhD · principal_investigator, University of California, San Francisco
All locations (1)
University of ChicagoRecruiting
Chicago, Illinois, United States
Achieving Routine Intervention and Screening for Emotional Health · TrialPath